C3 glomerulopathy and eculizumab: a report on four paediatric cases

C Lebreton, J Bacchetta, F Dijoud, L Bessenay… - Pediatric …, 2017 - Springer
Background Eculizumab may be used to treat C3-glomerulopathy (C3G), a rare but severe
glomerular disease. Diagnosis and Treatment Patients 1, 2 and 3 were diagnosed with …

C3 glomerulopathy and eculizumab: a report on four paediatric cases.

C Lebreton, J Bacchetta, F Dijoud… - Pediatric …, 2017 - search.ebscohost.com
Background: Eculizumab may be used to treat C3-glomerulopathy (C3G), a rare but severe
glomerular disease. Diagnosis and Treatment: Patients 1, 2 and 3 were diagnosed with …

C3 glomerulopathy and eculizumab: a report on four paediatric cases

C Lebreton, J Bacchetta, F Dijoud… - Pediatric …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Eculizumab may be used to treat C3-glomerulopathy (C3G), a rare but severe
glomerular disease. Diagnosis and treatment Patients 1, 2 and 3 were diagnosed with …

C3 glomerulopathy and eculizumab: a report on four paediatric cases

C Lebreton, J Bacchetta, F Dijoud, L Bessenay… - Pediatric …, 2017 - infona.pl
Background Eculizumab may be used to treat C3-glomerulopathy (C3G), a rare but severe
glomerular disease. Diagnosis and Treatment Patients 1, 2 and 3 were diagnosed with …

C3 glomerulopathy and eculizumab: a report on four paediatric cases.

C Lebreton, J Bacchetta, F Dijoud… - Pediatric Nephrology …, 2017 - europepmc.org
C3 glomerulopathy and eculizumab: a report on four paediatric cases. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

[引用][C] C3 glomerulopathy and eculizumab: a report on four paediatric cases

C Lebreton, J Bacchetta, F Dijoud, L Bessenay… - Pediatric …, 2017 - Springer